vs

Side-by-side financial comparison of MARAVAI LIFESCIENCES HOLDINGS, INC. (MRVI) and READING INTERNATIONAL INC (RDI). Click either name above to swap in a different company.

READING INTERNATIONAL INC is the larger business by last-quarter revenue ($50.3M vs $49.9M, roughly 1.0× MARAVAI LIFESCIENCES HOLDINGS, INC.). READING INTERNATIONAL INC runs the higher net margin — -5.1% vs -71.6%, a 66.5% gap on every dollar of revenue. On growth, MARAVAI LIFESCIENCES HOLDINGS, INC. posted the faster year-over-year revenue change (-11.8% vs -14.2%). READING INTERNATIONAL INC produced more free cash flow last quarter ($4.1M vs $-24.9M). Over the past eight quarters, READING INTERNATIONAL INC's revenue compounded faster (5.6% CAGR vs -11.9%).

Maravai LifeSciences Holdings is a global life sciences firm developing critical reagents, diagnostic products, and tech solutions to support biopharma research, drug development, clinical diagnostics, and cell/gene therapy manufacturing. It serves biotech, pharma, research bodies and labs worldwide across three core segments.

The Reading Company was a Philadelphia-headquartered railroad that provided passenger and freight transport in eastern Pennsylvania and neighboring states from 1924 until its acquisition by Conrail in 1976.

MRVI vs RDI — Head-to-Head

Bigger by revenue
RDI
RDI
1.0× larger
RDI
$50.3M
$49.9M
MRVI
Growing faster (revenue YoY)
MRVI
MRVI
+2.3% gap
MRVI
-11.8%
-14.2%
RDI
Higher net margin
RDI
RDI
66.5% more per $
RDI
-5.1%
-71.6%
MRVI
More free cash flow
RDI
RDI
$29.0M more FCF
RDI
$4.1M
$-24.9M
MRVI
Faster 2-yr revenue CAGR
RDI
RDI
Annualised
RDI
5.6%
-11.9%
MRVI

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
MRVI
MRVI
RDI
RDI
Revenue
$49.9M
$50.3M
Net Profit
$-35.7M
$-2.6M
Gross Margin
25.8%
Operating Margin
-117.9%
-1.9%
Net Margin
-71.6%
-5.1%
Revenue YoY
-11.8%
-14.2%
Net Profit YoY
-37.7%
-14.5%
EPS (diluted)
$-0.24
$-0.11

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MRVI
MRVI
RDI
RDI
Q4 25
$49.9M
$50.3M
Q3 25
$41.6M
$52.2M
Q2 25
$47.4M
$60.4M
Q1 25
$46.9M
$40.2M
Q4 24
$56.6M
$58.6M
Q3 24
$69.0M
$60.1M
Q2 24
$69.4M
$46.8M
Q1 24
$64.2M
$45.1M
Net Profit
MRVI
MRVI
RDI
RDI
Q4 25
$-35.7M
$-2.6M
Q3 25
$-25.6M
$-4.2M
Q2 25
$-39.6M
$-2.7M
Q1 25
$-29.9M
$-4.8M
Q4 24
$-25.9M
$-2.2M
Q3 24
$-97.1M
$-7.0M
Q2 24
$-9.8M
$-12.8M
Q1 24
$-12.1M
$-13.2M
Gross Margin
MRVI
MRVI
RDI
RDI
Q4 25
25.8%
Q3 25
13.6%
Q2 25
16.4%
Q1 25
16.5%
Q4 24
34.3%
Q3 24
46.7%
Q2 24
44.4%
Q1 24
40.3%
Operating Margin
MRVI
MRVI
RDI
RDI
Q4 25
-117.9%
-1.9%
Q3 25
-98.6%
-0.6%
Q2 25
-139.8%
4.8%
Q1 25
-104.9%
-17.2%
Q4 24
-66.7%
2.6%
Q3 24
-239.9%
-0.6%
Q2 24
-19.4%
-16.4%
Q1 24
-29.4%
-16.7%
Net Margin
MRVI
MRVI
RDI
RDI
Q4 25
-71.6%
-5.1%
Q3 25
-61.4%
-8.0%
Q2 25
-83.5%
-4.4%
Q1 25
-63.9%
-11.8%
Q4 24
-45.8%
-3.8%
Q3 24
-140.6%
-11.7%
Q2 24
-14.1%
-27.4%
Q1 24
-18.8%
-29.4%
EPS (diluted)
MRVI
MRVI
RDI
RDI
Q4 25
$-0.24
$-0.11
Q3 25
$-0.18
$-0.18
Q2 25
$-0.27
$-0.12
Q1 25
$-0.21
$-0.21
Q4 24
$-0.21
$-0.11
Q3 24
$-0.68
$-0.31
Q2 24
$-0.07
$-0.57
Q1 24
$-0.09
$-0.59

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MRVI
MRVI
RDI
RDI
Cash + ST InvestmentsLiquidity on hand
$216.9M
$10.5M
Total DebtLower is stronger
$291.8M
$185.1M
Stockholders' EquityBook value
$212.4M
$-18.2M
Total Assets
$770.6M
$434.9M
Debt / EquityLower = less leverage
1.37×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MRVI
MRVI
RDI
RDI
Q4 25
$216.9M
$10.5M
Q3 25
$243.6M
$8.1M
Q2 25
$269.9M
$9.1M
Q1 25
$285.1M
$5.9M
Q4 24
$322.4M
$12.4M
Q3 24
$578.2M
$10.1M
Q2 24
$573.2M
$9.3M
Q1 24
$561.7M
$7.5M
Total Debt
MRVI
MRVI
RDI
RDI
Q4 25
$291.8M
$185.1M
Q3 25
$292.8M
Q2 25
$293.9M
Q1 25
$294.9M
Q4 24
$295.9M
$202.7M
Q3 24
$521.7M
Q2 24
$522.5M
Q1 24
$523.3M
Stockholders' Equity
MRVI
MRVI
RDI
RDI
Q4 25
$212.4M
$-18.2M
Q3 25
$245.4M
$-12.1M
Q2 25
$265.9M
$-7.7M
Q1 25
$300.6M
$-8.1M
Q4 24
$325.3M
$-4.4M
Q3 24
$344.9M
$1.6M
Q2 24
$434.7M
$6.5M
Q1 24
$410.7M
$18.0M
Total Assets
MRVI
MRVI
RDI
RDI
Q4 25
$770.6M
$434.9M
Q3 25
$849.2M
$435.2M
Q2 25
$897.0M
$438.1M
Q1 25
$959.8M
$441.0M
Q4 24
$1.0B
$471.0M
Q3 24
$1.3B
$495.7M
Q2 24
$1.4B
$494.9M
Q1 24
$1.4B
$494.9M
Debt / Equity
MRVI
MRVI
RDI
RDI
Q4 25
1.37×
Q3 25
1.19×
Q2 25
1.11×
Q1 25
0.98×
Q4 24
0.91×
Q3 24
1.51×
Q2 24
1.20×
Q1 24
1.27×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MRVI
MRVI
RDI
RDI
Operating Cash FlowLast quarter
$-22.8M
$4.3M
Free Cash FlowOCF − Capex
$-24.9M
$4.1M
FCF MarginFCF / Revenue
-49.9%
8.2%
Capex IntensityCapex / Revenue
4.2%
0.3%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-70.7M
$-2.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MRVI
MRVI
RDI
RDI
Q4 25
$-22.8M
$4.3M
Q3 25
$-15.2M
$295.0K
Q2 25
$-10.3M
$1.6M
Q1 25
$-9.4M
$-7.7M
Q4 24
$-14.6M
$8.0M
Q3 24
$13.1M
$1.3M
Q2 24
$17.4M
$-10.4M
Q1 24
$-8.5M
$-2.8M
Free Cash Flow
MRVI
MRVI
RDI
RDI
Q4 25
$-24.9M
$4.1M
Q3 25
$-18.1M
$-246.0K
Q2 25
$-13.1M
$1.2M
Q1 25
$-14.6M
$-8.0M
Q4 24
$-20.5M
$7.0M
Q3 24
$4.5M
$-1.1M
Q2 24
$7.9M
$-10.6M
Q1 24
$-14.1M
$-4.7M
FCF Margin
MRVI
MRVI
RDI
RDI
Q4 25
-49.9%
8.2%
Q3 25
-43.4%
-0.5%
Q2 25
-27.7%
1.9%
Q1 25
-31.2%
-19.8%
Q4 24
-36.2%
12.0%
Q3 24
6.6%
-1.8%
Q2 24
11.4%
-22.7%
Q1 24
-22.0%
-10.4%
Capex Intensity
MRVI
MRVI
RDI
RDI
Q4 25
4.2%
0.3%
Q3 25
7.0%
1.0%
Q2 25
6.1%
0.6%
Q1 25
11.2%
0.6%
Q4 24
10.3%
1.7%
Q3 24
12.4%
4.0%
Q2 24
13.8%
0.5%
Q1 24
8.8%
4.3%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

MRVI
MRVI

Cygnus Segment$27.2M54%
Other$18.4M37%
Shipping And Handling$4.3M9%

RDI
RDI

Cinema Exhibition Segment$46.9M93%
Real Estate Revenue$3.4M7%

Related Comparisons